Quantification of DNase type I ends, DNase type II ends, and modified bases using fluorescently labeled ddUTP, terminal deoxynucleotidyl transferase, and formamidopyrimidine-DNA glycosylase

Here we describe the substitution of fluorescently labeled ddUTP for dUTP in the TUNEL assay to allow quantification of generated fluorescence signals by epifluorescence microscopy. The capping of DNase type I 3′OH DNA ends using ddTUNEL was further combined with phosphatase treatment for detection...

Full description

Saved in:
Bibliographic Details
Main Authors: David S. Baskin, Marsha A. Widmayer, Martyn A. Sharpe
Format: Article
Language:English
Published: Taylor & Francis Group 2010-07-01
Series:BioTechniques
Subjects:
Online Access:https://www.future-science.com/doi/10.2144/000113439
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850152669975412736
author David S. Baskin
Marsha A. Widmayer
Martyn A. Sharpe
author_facet David S. Baskin
Marsha A. Widmayer
Martyn A. Sharpe
author_sort David S. Baskin
collection DOAJ
description Here we describe the substitution of fluorescently labeled ddUTP for dUTP in the TUNEL assay to allow quantification of generated fluorescence signals by epifluorescence microscopy. The capping of DNase type I 3′OH DNA ends using ddTUNEL was further combined with phosphatase treatment for detection of DNase type II 3′PO4 ends in the same sample using a second round of ddTUNEL. Levels of modified DNA bases in tissues and fixed cultured cells could be interrogated in the ddTUNEL assay with the base modification repair enzyme formamidopyrimidine DNA glycosylase. Using rat mammary gland, from days 1 and 7 of involution, we validate the methodology's ability to label apoptotic nuclei and apoptotic inclusion bodies. In addition, we examined the types of DNA damage and modification that occur in human glioblastoma, U87 cells, following exposure to reactive oxygen stressing agents, chemotherapeutic alkylating agents, and a topoisomerase I inhibitor, irinotecan.
format Article
id doaj-art-6ea678e18db74fba98d3f6f8aedc138f
institution OA Journals
issn 0736-6205
1940-9818
language English
publishDate 2010-07-01
publisher Taylor & Francis Group
record_format Article
series BioTechniques
spelling doaj-art-6ea678e18db74fba98d3f6f8aedc138f2025-08-20T02:25:55ZengTaylor & Francis GroupBioTechniques0736-62051940-98182010-07-0149150551210.2144/000113439Quantification of DNase type I ends, DNase type II ends, and modified bases using fluorescently labeled ddUTP, terminal deoxynucleotidyl transferase, and formamidopyrimidine-DNA glycosylaseDavid S. Baskin0Marsha A. Widmayer1Martyn A. Sharpe21Department of Neurosurgery, The Methodist Hospital, Houston, TX, USA1Department of Neurosurgery, The Methodist Hospital, Houston, TX, USA1Department of Neurosurgery, The Methodist Hospital, Houston, TX, USAHere we describe the substitution of fluorescently labeled ddUTP for dUTP in the TUNEL assay to allow quantification of generated fluorescence signals by epifluorescence microscopy. The capping of DNase type I 3′OH DNA ends using ddTUNEL was further combined with phosphatase treatment for detection of DNase type II 3′PO4 ends in the same sample using a second round of ddTUNEL. Levels of modified DNA bases in tissues and fixed cultured cells could be interrogated in the ddTUNEL assay with the base modification repair enzyme formamidopyrimidine DNA glycosylase. Using rat mammary gland, from days 1 and 7 of involution, we validate the methodology's ability to label apoptotic nuclei and apoptotic inclusion bodies. In addition, we examined the types of DNA damage and modification that occur in human glioblastoma, U87 cells, following exposure to reactive oxygen stressing agents, chemotherapeutic alkylating agents, and a topoisomerase I inhibitor, irinotecan.https://www.future-science.com/doi/10.2144/000113439TUNELddUTPformamidopyrimidine-DNA glycosylaseDNaseapoptosismammary gland
spellingShingle David S. Baskin
Marsha A. Widmayer
Martyn A. Sharpe
Quantification of DNase type I ends, DNase type II ends, and modified bases using fluorescently labeled ddUTP, terminal deoxynucleotidyl transferase, and formamidopyrimidine-DNA glycosylase
BioTechniques
TUNEL
ddUTP
formamidopyrimidine-DNA glycosylase
DNase
apoptosis
mammary gland
title Quantification of DNase type I ends, DNase type II ends, and modified bases using fluorescently labeled ddUTP, terminal deoxynucleotidyl transferase, and formamidopyrimidine-DNA glycosylase
title_full Quantification of DNase type I ends, DNase type II ends, and modified bases using fluorescently labeled ddUTP, terminal deoxynucleotidyl transferase, and formamidopyrimidine-DNA glycosylase
title_fullStr Quantification of DNase type I ends, DNase type II ends, and modified bases using fluorescently labeled ddUTP, terminal deoxynucleotidyl transferase, and formamidopyrimidine-DNA glycosylase
title_full_unstemmed Quantification of DNase type I ends, DNase type II ends, and modified bases using fluorescently labeled ddUTP, terminal deoxynucleotidyl transferase, and formamidopyrimidine-DNA glycosylase
title_short Quantification of DNase type I ends, DNase type II ends, and modified bases using fluorescently labeled ddUTP, terminal deoxynucleotidyl transferase, and formamidopyrimidine-DNA glycosylase
title_sort quantification of dnase type i ends dnase type ii ends and modified bases using fluorescently labeled ddutp terminal deoxynucleotidyl transferase and formamidopyrimidine dna glycosylase
topic TUNEL
ddUTP
formamidopyrimidine-DNA glycosylase
DNase
apoptosis
mammary gland
url https://www.future-science.com/doi/10.2144/000113439
work_keys_str_mv AT davidsbaskin quantificationofdnasetypeiendsdnasetypeiiendsandmodifiedbasesusingfluorescentlylabeledddutpterminaldeoxynucleotidyltransferaseandformamidopyrimidinednaglycosylase
AT marshaawidmayer quantificationofdnasetypeiendsdnasetypeiiendsandmodifiedbasesusingfluorescentlylabeledddutpterminaldeoxynucleotidyltransferaseandformamidopyrimidinednaglycosylase
AT martynasharpe quantificationofdnasetypeiendsdnasetypeiiendsandmodifiedbasesusingfluorescentlylabeledddutpterminaldeoxynucleotidyltransferaseandformamidopyrimidinednaglycosylase